Reckitt Benckiser Group (RKT.L) Stock Analysis & Winston Score
Reckitt Benckiser is a British consumer goods company that makes health, hygiene, and nutrition products sold in homes around the world. Its brands include Dettol, Lysol, Durex, Nurofen, Strepsils, and Enfamil baby formula. The company sells mainly to everyday consumers through supermarkets, pharmacies, and online retailers. Reckitt earns money by selling these branded products directly to retailers and distributors, who then sell them to shoppers. It operates in over 60 countries, with strong sales across North America, Europe, and Asia, and generates roughly $15 billion in annual revenue. Its main competitive advantage is its portfolio of trusted, well-known brands in categories where consumers tend to stick with familiar names. The biggest risk the company faces is ongoing legal and financial pressure related to its Enfamil baby formula products, where lawsuits have alleged links to a serious intestinal condition in premature infants, creating significant uncertainty around future costs.
Winston Score: 53/100 — Average
Mixed quality — meaningful strengths and weaknesses.
- Quality: Strong (23/30)
- Growth: Mixed (7/20)
- Cash Flow: Good (5/10)
- Stability: Good (6/10)
- Valuation: Good (5/10)
- Ownership: Weak (2/15)
Key Facts
Price: 5,142.00 GBp
Market Cap: £32.7B
Sector: Consumer Defensive
Industry: Household & Personal Products
Exchange: London Stock Exchange

